Shares of Inovio Pharmaceuticals Inc. (NASDAQ:INO) have received a consensus recommendation of “Buy” from the nine analysts that are currently covering the company. Two investment analysts have rated the stock with a hold rating and seven have given a buy rating to the company. The average 1 year target price among analysts that have covered […]